Embracing the New Era of Immunotherapy in Gastric Cancer Treatment
Advanced gastric cancer still presents a grim outlook, typically yielding a median survival rate of approximately 12 to 15 months. Recently, immune checkpoint inhibitors have emerged as a promising standard treatment for various malignancies, including advanced gastric cancer. They have shown signif...
| 發表在: | South African Gastroenterology Review |
|---|---|
| 主要作者: | |
| 格式: | Article |
| 語言: | English |
| 出版: |
In House Publications
2024
|
| 在線閱讀: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182387330&partnerID=40&md5=7d1efd0df491f5c8afbc75fd971cca9c |